2. INTRODUCTION
An immunoassay is a specific type of biochemical test that
measures the presence or concentration of a substance
(referred to as the "analyte") in solutions that frequently
contain a complex mixture of substances.
3. INTRODUCTION
Antibody/Antigen reaction provides the means of
generating a measurable result.
“Immuno” refers to an immune response that causes the
body to generate antibodies.
“Assay” refers to a test.
An immunoassay is a test that uses immunocomplexing
when antibodies and antigens are brought together.
4. INTRODUCTION
An antibody is a protein produced in the body to a foreign
substance.
An antigen is the substance that the body is trying to
eliminate by mounting an immune response.
An analyte is anything measured by a laboratory test.
Immunoassays may measure either the antigen or
antibody.
Immunoassays use one or more select antibodies to detect
analytes of interest.
LABEL
5. LABEL
All immunoassays require the use of labeled material in
order to measure the amount of antigen or antibody
present.
A label is a molecule that will react as part of the assay,
so a change in signal can be measured in the
blood:reagent solution.
EXAMPLES
6. Examples of a label
a radioactive compound,
an enzyme that causes a change of color in a solution,
or a substance that produces light.
8. Competitive Assays
In a competitive format,
unlabeled analyte (usually
the antigen) in the test
sample is measured by its
ability to compete with
the labeled antigen in the
immunoassay.
In a competitive
immunoassay, less label
measured in the assay
means more of the
unlabeled (test sample)
antigen is present.
•
There are two versions of the
competitive format:
• One Step format
• Two step format
9. One step competitive format
In the one step competitive format , both the labeled antigen
reagent (Ag*) and the unlabeled specimen (or test sample
analyte) compete for a limited amount of antibody.
10. Two step competitive format
In the two step competitive format, the antibody concentration
of the reaction solution is present in excess in comparison to
the concentration of antigen.
Antibody reagent is first incubated with specimen containing
antigens of interest; then in the second step, labeled antigen is
added.
More sensitive than one step.
11.
12. Noncompetitive Assays
Noncompetitive assay formats give
the highest level of sensitivity and
specificity.
They are normally used to measure
critical analytes such as cardiac and
hepatitis markers.
•
In noncompetitive assays, the measurement
of the labeled analyte (usually the antibody)
is directly proportional to the amount of
antigen present in the sample.
13. Enzyme Immunoassay (EIA)
In enzyme immunoassays (EIA), enzyme labels
are used.
Typical enzyme labels include alkaline
phosphatase, horseradish peroxidase and galatosidase.
EIA tests typically use a change in color,
emmission of light or other signal.
14.
15.
A sandwich ELISA.
(1) Plate is coated with a capture antibody;
(2) sample is added, and any antigen present binds to capture
antibody;
(3) detecting antibody is added, and binds to antigen;
(4) enzyme-linked secondary antibody is added, and to
detecting antibody;
(5) substrate is added, and is converted by enzyme to
detectable form.
17. Radioimmunoassay (RIA)
Very sensitive in vitro assay technique
Less expensive
Radioactive substances are used
Commonly used radioisotope is I 125
Micro curies of radioactivity – minimum radiation
Micro-gram and Pico-gram quantities of substances can be
analyzed.
18. RAST
Radioallergosorbent test
Modification of RIA
Antigen attached to plate well – allergen
Radio labeled ligand used will attach only to IgE antibody –
specific for allergen.
Used to detect specific allergen in persons suspected to be
suffering from Type I hypersensitivity.
19. Fluorescence Polarization Immunoassay (FPIA)
Homogeneous competitive fluoresence immunoassay.
With competitive binding, antigen from the specimen and antigenfluorescein (AgF) labeled reagent compete for binding sites on the
antibody.
FPIA is used to provide accurate and sensitive measurements of small
toxicological analytes such as therapeutic drugs and drugs of abuse.
20. Fluorescence Polarization Immunoassay
FPIA uses three concepts to measure specific analytes in a
homogeneous format:
Fluorescence
Rotation of molecules in solution
Polarized light
21. Fluorescence
Fluorescein is a fluorescence label that absorbs light at 490 nm and
releases this energy at 520 nm.
Larger molecules rotate more slowly in solution that smaller
molecules.
Because of this, we can distinguish between the smaller antigenfluorescein (AgF) label from antibody bound antigen-fluorescein (AbAgF).
22. Surround Optical Fiber Immunoassay (SOFIA)
an ultra-sensitive,
in vitro diagnostic platform incorporating a surround
optical fiber assembly that captures fluorescence
emissions from an entire sample.
extremely high limit of detection , sensitivity and
dynamic range.
sensitivity is measured at the attogram level (10−18g),
making it approximately one billion times more sensitive
than conventional diagnostic techniques.
23. Surround Optical Fiber Immunoassay (SOFIA)
ability to detect naturally occurring prions in the blood
and urine of disease carriers
first reliable ante mortem screening test for vCJD, scrapie
and other transmissible spongiform encephalopathies
24. Magnetic immunoassay
novel type of diagnostic immunoassay
using magnetic beads as labels
involves the specific binding of an antibody to its antigen,
where a magnetic label is conjugated to one element of
the pair.
The presence of magnetic beads is then detected by a
magnetic reader (magnetometer) which measures the
magnetic field change induced by the beads.
The signal measured by the magnetometer is
proportional to the analyte (virus, toxin, bacteria, cardiac
marker,etc.) quantity in the initial sample.
25. References
Text book of Biochemistry for medical students by DM
Vasudevan
Textbook of Microbiology, Annanth narayan.
Wikipedia